Sra III LLC is a venture capital fund based in New York, New York. According to its most recent Form D, filed Aug 13, 2014, it has sold $243,934 of interests to 7 investors since its first sale in Jul 2014. The filing does not set a minimum investment. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include John Bivona; Stephen Soler.
- Total raised
- $243,934Cumulative sales reported on Form D
- Investors
- 7
- First sale
- Jul 28, 2014
- Minimum investment
- None set
- Who can invest
- Not stated
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- John Bivona; Stephen Soler
- Latest Form D
- Aug 13, 2014
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Sra III LLC
What is the minimum investment for Sra III LLC?
Sra III LLC's latest Form D, filed Aug 13, 2014, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Sra III LLC?
Sra III LLC is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has Sra III LLC raised?
Sra III LLC reports $243,934 sold from 7 investors on its Form D filed Aug 13, 2014. This is cumulative sales since the offering began, not current assets or performance.
Where is Sra III LLC based?
Sra III LLC is based in New York, New York.
When did Sra III LLC launch?
Sra III LLC reports its first sale in Jul 2014.
Size compared with every venture capital fund
Raised more than 36% of the 1,239 venture capital funds based in New York, and more than 34% of all 14,865 that report sales.